Nov 17, 2021 7:00am EST A Second Independent Proxy Advisor, ISS, Recommends ProMIS Neurosciences Shareholders Vote for the Share Consolidation
Nov 02, 2021 7:00am EDT Glass Lewis Recommends ProMIS Neurosciences Shareholders Vote for the Share Consolidation at the Upcoming Special Meeting
Oct 22, 2021 7:00am EDT ProMIS Neurosciences Appoints Accomplished Biotech Executive, Dr. Maggie Shafmaster, to its Board of Directors
Sep 15, 2021 7:30am EDT ProMIS Neurosciences to Present at the Second Annual Undruggable Leaders Forum, September 15-16, 2021
Sep 13, 2021 7:30am EDT ProMIS Neurosciences to Participate in H.C. Wainwright & Co. 23rd Annual Investment Conference
Sep 01, 2021 7:30am EDT ProMIS Neurosciences appoints accomplished biotechnology executive, Josh Mandel-Brehm, to its Board of Directors